Form 4 for LPCN Lipocine Inc.
Accepted 2024-03-12 00:00:00 ET · period of report 2024-03-08 · accession 0001493152-24-009707 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-12 | 2024-03-08 | LPCN | Patel Mahesh V. | CEO, Pres, Dir | A - Grant | $0.00 | +4,893 | 112.3K | +5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-08 | A | A | 4,893 | $0.00 | 112,311 | D | — | — | (F1) Restricted stock units subject to vesting whereby 1/3 of the shares subject to the award will vest on the one-year anniversary of March 8, 2025, while the remaining 2/3 of the shares subject to the award will vest semi-annually on a prorated basis over the following two years. |